Heart failure is a risk factor for adverse events such as sudden cardiac arrest, liver and
kidney failure and death. The gut microbiota and its metabolites are directly linked to the …

Aims Heart failure (HF) is one of the most frequent diagnoses for 30-day readmission after
hospital discharge. Nurses have role in reducing unplanned readmission and providing …

Background There are few contemporary data on outcomes, costs, and treatment following a
hospitalization for heart failure (hHF) in epidemiologically representative cohorts. Objectives …

Background Cardiac fibroblast activation protein (FAP) has an emerging role in heart failure
(HF). A paradoxical reduction in its levels in pathological conditions associated with acute …

Heart failure (HF) is associated with disabling symptoms, poor quality of life, and a poor
prognosis with substantial excess mortality in the years following diagnosis. Overactivation …

Background Heart failure has an estimated global prevalence of 64.3 million cases, with an
average age of a person living with heart failure at 75.2 years. Approximately 20% of …

Background Kidney dysfunction often leads to reluctance to start or continue life-saving
heart failure (HF) therapy. Objectives This study sought to examine the efficacy and safety of …

Heart failure (HF) is a complex, progressive disorder that is associated with substantial
morbidity and mortality on a global scale. Relaxin‐2 is a naturally occurring hormone that …

Heart Failure (HF) is common, with worldwide prevalence of 1%-3% and a lifetime risk of
20% for individuals 40 years or older. Despite its considerable health economic burden …

The associations of plasma metabolites with adverse cardiovascular (CV) outcomes are still
underexplored and may be useful in CV risk stratification. We performed a systematic review …